COVID-19 Outbreak : Pathogenesis, Current Therapies, and Potentials for Future Management
Copyright © 2020 Hossain, Hasana, Mamun, Uddin, Wahed, Sarker, Behl, Ullah, Begum, Bulbul, Amran, Rahman, Bin-Jumah, Alkahtani, Mousa, Aleya and Abdel-Daim..
At the end of 2019, a novel coronavirus (CoV) was found at the seafood market of Hubei province in Wuhan, China, and this virus was officially named coronavirus diseases 2019 (COVID-19) by World Health Organization (WHO). COVID-19 is mainly characterized by severe acute respiratory syndrome coronavirus-2 (SARS-CoV2) and creates public health concerns as well as significant threats to the economy around the world. Unfortunately, the pathogenesis of COVID-19 is unclear and there is no effective treatment of this newly life-threatening and devastating virus. Therefore, it is crucial to search for alternative methods that alleviate or inhibit the spread of COVID-19. In this review, we try to find out the etiology, epidemiology, symptoms as well as transmissions of this novel virus. We also summarize therapeutic interventions and suggest antiviral treatments, immune-enhancing candidates, general supplements, and CoV specific treatments that control replication and reproduction of SARS-CoV and Middle East respiratory syndrome coronavirus (MERS-CoV).
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:11 |
|---|---|
| Enthalten in: |
Frontiers in pharmacology - 11(2020) vom: 20., Seite 563478 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Hossain, Md Farhad [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Coronavirus |
|---|
| Anmerkungen: |
Date Revised 30.03.2024 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.3389/fphar.2020.563478 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM317455915 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM317455915 | ||
| 003 | DE-627 | ||
| 005 | 20240330233633.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3389/fphar.2020.563478 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1356.xml |
| 035 | |a (DE-627)NLM317455915 | ||
| 035 | |a (NLM)33178016 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Hossain, Md Farhad |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a COVID-19 Outbreak |b Pathogenesis, Current Therapies, and Potentials for Future Management |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 30.03.2024 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a Copyright © 2020 Hossain, Hasana, Mamun, Uddin, Wahed, Sarker, Behl, Ullah, Begum, Bulbul, Amran, Rahman, Bin-Jumah, Alkahtani, Mousa, Aleya and Abdel-Daim. | ||
| 520 | |a At the end of 2019, a novel coronavirus (CoV) was found at the seafood market of Hubei province in Wuhan, China, and this virus was officially named coronavirus diseases 2019 (COVID-19) by World Health Organization (WHO). COVID-19 is mainly characterized by severe acute respiratory syndrome coronavirus-2 (SARS-CoV2) and creates public health concerns as well as significant threats to the economy around the world. Unfortunately, the pathogenesis of COVID-19 is unclear and there is no effective treatment of this newly life-threatening and devastating virus. Therefore, it is crucial to search for alternative methods that alleviate or inhibit the spread of COVID-19. In this review, we try to find out the etiology, epidemiology, symptoms as well as transmissions of this novel virus. We also summarize therapeutic interventions and suggest antiviral treatments, immune-enhancing candidates, general supplements, and CoV specific treatments that control replication and reproduction of SARS-CoV and Middle East respiratory syndrome coronavirus (MERS-CoV) | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Middle East respiratory syndrome coronavirus | |
| 650 | 4 | |a coronavirus | |
| 650 | 4 | |a coronavirus disease 2019 | |
| 650 | 4 | |a severe acute respiratory syndrome coronavirus-2 | |
| 650 | 4 | |a therapeutic interventions | |
| 650 | 4 | |a transmission | |
| 700 | 1 | |a Hasana, Sharifa |e verfasserin |4 aut | |
| 700 | 1 | |a Mamun, Abdullah Al |e verfasserin |4 aut | |
| 700 | 1 | |a Uddin, Md Sahab |e verfasserin |4 aut | |
| 700 | 1 | |a Wahed, Mir Imam Ibne |e verfasserin |4 aut | |
| 700 | 1 | |a Sarker, Sabarni |e verfasserin |4 aut | |
| 700 | 1 | |a Behl, Tapan |e verfasserin |4 aut | |
| 700 | 1 | |a Ullah, Irfan |e verfasserin |4 aut | |
| 700 | 1 | |a Begum, Yesmin |e verfasserin |4 aut | |
| 700 | 1 | |a Bulbul, Israt Jahan |e verfasserin |4 aut | |
| 700 | 1 | |a Amran, Md Shah |e verfasserin |4 aut | |
| 700 | 1 | |a Rahman, Md Habibur |e verfasserin |4 aut | |
| 700 | 1 | |a Bin-Jumah, May N |e verfasserin |4 aut | |
| 700 | 1 | |a Alkahtani, Saad |e verfasserin |4 aut | |
| 700 | 1 | |a Mousa, Shaker A |e verfasserin |4 aut | |
| 700 | 1 | |a Aleya, Lotfi |e verfasserin |4 aut | |
| 700 | 1 | |a Abdel-Daim, Mohamed M |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Frontiers in pharmacology |d 2010 |g 11(2020) vom: 20., Seite 563478 |w (DE-627)NLM208568891 |x 1663-9812 |7 nnns |
| 773 | 1 | 8 | |g volume:11 |g year:2020 |g day:20 |g pages:563478 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.3389/fphar.2020.563478 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 11 |j 2020 |b 20 |h 563478 | ||